Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | PAN domain-containing protein | 0.0341 | 0.477 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0145 | 0.1658 | 0.1658 |
Brugia malayi | jmjC domain containing protein | 0.0057 | 0.026 | 0.1571 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0041 | 0 | 0.5 |
Schistosoma mansoni | jumonji domain containing protein | 0.0057 | 0.026 | 0.026 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0041 | 0 | 0.5 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0057 | 0.026 | 0.026 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0057 | 0.026 | 0.026 |
Onchocerca volvulus | 0.0041 | 0 | 0.5 | |
Toxoplasma gondii | PAN domain-containing protein | 0.0341 | 0.477 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0145 | 0.1658 | 0.1658 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 0.1658 | 1 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0057 | 0.026 | 0.026 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0041 | 0 | 0.5 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0057 | 0.026 | 0.026 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0057 | 0.026 | 0.026 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0057 | 0.026 | 0.1571 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0057 | 0.026 | 0.026 |
Brugia malayi | Muscleblind-like protein | 0.0145 | 0.1658 | 1 |
Schistosoma mansoni | microtubule-associated protein tau | 0.067 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 0.1658 | 1 |
Echinococcus multilocularis | muscleblind protein | 0.0145 | 0.1658 | 0.1658 |
Leishmania major | hypothetical protein, conserved | 0.0041 | 0 | 0.5 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.067 | 1 | 1 |
Brugia malayi | jmjC domain containing protein | 0.0057 | 0.026 | 0.1571 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | 0 | Inhibition of ENT1 in human K562 cells by flow cytometric assay | ChEMBL. | 17636949 |
Inhibition (binding) | = 9.9 % | Inhibition of ENT1 in human K562 cells at 10 uM by flow cytometric assay | ChEMBL. | 17636949 |
Inhibition (binding) | = 9.9 % | Inhibition of ENT1 in human K562 cells at 10 uM by flow cytometric assay | ChEMBL. | 17636949 |
Ki (binding) | 0 | Inhibition of ENT1 in human K562 cells by flow cytometric assay | ChEMBL. | 17636949 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.